B lymphocytes develop from hematopoietic stem cells through an orderly process of differentiation that results in antigen-responsive B cells with individual immuno globulin surface receptors. This developmental process can be dissected into different stages according to the expression of specific cell surface markers and the se quential rearrangement of immunoglobulin heavy [IgH] and light [IgL] chain genes (for review, see Rolink and Melchers 1991) . In addition, B-cell populations can be distinguished by their growth factor requirements (Hayashi et al. 1990 ). In the classification scheme of Hardy et al. (1991) , sequential stages of mouse B cell development have been divided into seven distinct cell fractions (A-F) based on differential expression of CD43, heat stable an tigen (HSA), BP-1, IgM, and IgD ( Fig. 1; bottom) . Rohnk et al. (1994) have instead used the analysis of cell size ^Corresponding author. E-MAIL Busslinger@ainip.una.ac.at; and the expression of c-kit, CD25, and the surrogate light chains VpreB and X5 to fractionate B lymphocytes ac cording to their developmental stage (Fig. 1, top) . As shown by these studies, the earliest B-cell progenitors in the bone marrow are large cycling cells expressing CD43, c-kit, as well as the surrogate light chain proteins on their surface (Hardy et al. 1991; Karasuyama et al. 1994; Rolink et al. 1994) , are in the process of D^-to-Zn rear rangement of the IgH locus (Ehlich et al. 1993; Li et al. 1993; ten Boekel et al. 1995) and can be cloned in vitro on stromal cells in the presence of IL-7 (Rolink et al. 1991b ). Completion of a productive Vj^-to-DyJ^^ rearrangement results in transient expression of the ]i chain in associa tion with the surrogate light chain proteins on the cell surface (Karasuyama et al. 1990 Tsubata and Reth 1990; Winkler et al. 1995) . Signaling through this pre-B cell receptor transiently down-regulates expression of the recombination activating genes RAG-1 and RAG-2 (Grawunder et al. 1995) , promotes allelic exclusion at the IgH locus (Kitamura and Rajewsky 1992; Loffert et Rolink et al. (1994) [top] or Hardy et al. (1991) [bottom] . The pan-B cell marker B220 is expressed at all stages. The predominant configuration of the immunoglobulin genes at each devel opmental stage is indicated, as it was deter mined by ten Boekel et al. (1995) (Rolink's nomenclature) and by Ehlich et al. (1993 Ehlich et al. ( , 1994 ) (Hardy's nomenclature) . Large and small circles denote proliferating and rest ing cells, respectively. Cells destined to die are indicated by wavy outlines. As the cor relation between the two classification sys tems is not straightforward in all aspects, the reader is referred to the original litera ture for details. (GL) Germ line; (SL) surro gate light chain; (IgH) immunoglobulin heavy chain; (IgL) immunoglobulin light chain; (HSA) heat-stable antigen. al. 1996) , and induces proliferative cell expansion Rolink et al. 1994) as well as differ entiation to small pre-B cells . FolloMring successful IgL (K or X) gene rearrange ment, immature B cells emerge that synthesize the IgM form of the B-cell receptor and become subjected to se lection by antigen. Subsequent expression of homing re ceptors enables these cells to populate peripheral lym phoid organs M^here they participate as mature B cells in immunological reactions (Lav^ and Clark 1994) .
Several transcription factors have been identified re cently that regulate important aspects of B-cell develop ment (for review, see Busslinger and Urbanek 1995; Hagman and Grosschedl 1994) . Among them is the B-cellspecific activator protein (BSAP), which is encoded by the Pax5 gene . This transcription factor is expressed at all stages of B lymphopoiesis except in terminally differentiated plasma cells (Barberis et al. 1990) , recognizes DNA via its amino-terminal paired do main (Czerny et al. 1993) , and uses a carboxy-terminal regulatory module consisting of activating and inhibi tory sequences to control gene transcription (Dorfler and Busslinger 1996) . BSAP (Pax5) has been implicated in the regulation of several B-cell-specific genes primarily based on the identification of BSAP-binding sites in their control regions. Putative BSAP targets are the le pro moter (Liao et al. 1994 ) and 3' enhancers of the IgH and IgL^ loci (Singh and Birshtein 1993; Neurath et al. 1994; Roque et al. 1996) as well as the genes coding for the cell surface protein CD19 , the tyrosine kinase Blk (Zwollo and Desiderio 1994) , the transcrip tion factor XBP-1 (Reimold et al. 1996) , and the surrogate light chains \5 and VpreBl (Okabe et al. 1992) .
Targeted inactivation of the Pax5 gene in the mouse germ line revealed essential functions of this transcrip tion factor in early B-lymphopoiesis and midbrain devel opment (Urbanek et al. 1994) . Pax5 mutant mice fail to produce small pre-B, B, and plasma cells and therefore lack any immunoglobulin in their serum owing to a complete arrest of B-cell development at an early stage. The bone marrow of these mice generates, however, large B220'' CD43^ B lymphocytes characteristic of early B-cell progenitors (Urbanek et al. 1994 ; see Fig. 1 ). Here we have determined the precise developmental stage of the differentiation block by extensive analysis of the ex pression profile of cell surface proteins and the rearrange ment status of immunoglobulin genes in Pax5-deficient B lymphocytes. These experiments revealed a differen tial requirement for Pax5 in fetal and adult B lympho poiesis. Whereas Pax5 is essential for progression beyond the early pro-B (pre-BI) cell stage in bone marrow, it is required for differentiation of the earliest B-lineage-committed precursor cells in the fetal liver. The pre-BI cells from Pax5-deficient bone marrow could be cultured in vitro on stromal cells in the presence of IL-7 and were shown to lack expression of the BSAP target gene CD19. Moreover, these pre-BI cells have efficiently undergone only Dj^-to-ZH rearrangements at the IgH locus which implies a role for Pax5 in the developmental pathway controlling Vj^-to-DiJ^ recombination.
Results

B-cell development is arrested at the early pro-B (pre-BI) cell stage in bone marrow of PaxS-deficient mice
Our previous phenotypic analysis of PaxS mutant mice demonstrated that the absence of PaxS arrests B-cell de velopment in the bone marrow at an early stage corre sponding to large B220"'CD43"' B lymphocytes (Urbanek et al. 1994) . As indicated in Figure 1 , these early B lym phocytes can be subdivided into different developmental Stages according to the expression of the surface markers HSA, . To further charac terize the Pax5-dependent differentiation blocks we have used antibodies recognizing these stage-specific proteins for flow cytometric analysis of bone marrow cells from Pax5 mutant and control wild-type mice. Because the majority of Pax5 mutant mice die within 3 weeks after birth (Urbanek et al. 1994) , we have analyzed the B-cell compartment (defined by expression of the pan-B-cell marker B220) only up to the age of 2 weeks when these mice are still largely free of disease symptoms. As illus trated in Figure 2A (and data not shown), the majority of the B220^CD43^ B lymphocytes in Pax5-deficient bone marrow express c-kit, HSA, IL-7R, and \5 (3-3.8% of all cells). The same cells, however, lack CD25, BP-1, and markers of late B-cell differentiation (IgM, IgD, CD21, CD23, CD40) on their cell surface in contrast to wildtype bone marrow cells. This expression profile defines the Pax5-deficient B lymphocytes as early pro-B cells of fraction B in Hardy's nomenclature (Hardy et al. 1991 ; Fig. 1 ), and as pro/pre-BI cells in the classification scheme of Rolink et al. (1994) (Fig. 1) . A small subset of Pax5-deficient B220"CD43" cells (-1%; Fig. 2A ) ex presses neither of the early markers c-kit, HSA, and IL-7R and is therefore likely to correspond to Hardy's frac tion A (see Fig. 1 ), which even includes non-B-lymphoid cells such as progenitors of natural killer cells . The proliferation of Pax5-deficient B lymphocytes was next studied by separating bone marrow cells of Pax5 mutant mice by fluorescence-activated cell sorting into B220^c-Ait'^ and B220*c-kit~ cells. Nuclei were prepared from both cell fractions, and their DNA content was analyzed by flow cytometry (Fig. 2B) . Only relatively few B220^c-icir cells (8%) in fraction A proved to be in the cell cycle. In contrast, 40% of all B220"c-icit" cells in fraction B were in the S, G2 or M phase of the cell cycle, which compares favorably with 45% measured for the B220"'c-kit* cell population in wild-type bone marrow . We conclude, therefore, that Pax5 is A 10' Figure 2 . B-cell development is blocked at the pre-BI cell stage in bone marrow of Pax5 mutant mice. {A) Flow cytometric analysis. Bone marrow cells from Pax5 mutant (-/-) and wild-type (+/+) mice at the age of 2 weeks were analyzed by flow cytometry using a FITC-conjugated anti-B220/CD45R antibody (RA3-6B2) in combination with either a biotinylated anti-CD43 (S7), anti-HSA (CD24; Ml/69), anti-c-kit (ACK4), anti-IL-7R (A7R34), anti-CD25 (IL-2Ra; 7D4) or anti-BP-1 (6C3) antibody. Biotin-conjugated antibod ies were revealed by incubation with PEcoupled streptavidin. (Ehlich et al. 1994; ten Boekel et al. 1995) . In the first PCR reaction, the IgH and IgL^ loci were amplified simultaneously with a mixture of 11 5' primers homologous to V^/ ^^> ^H and upstream f^l sequences in combination with two 3' primers located downstream of the 7^4 and /^5 segments. In the second round of amplification, the products of the first PCR were analyzed in separate reactions with primer combi nations that were specific for each rearrangement event (Ehlich et al. 1994; ten Boekel et al. 1995) . As summa rized in Figure 3 , PCR products were obtained in this manner from 54 B220"^c-7cii* cells of Pax5-deficient bone marrow. These amplified DNA fragments were charac terized according to their size (ten Boekel et al. 1995) , and 27 of them were cloned at random followed by DNA sequencing (Fig. 3B ). This analysis indicated that 9 alle les of the IgH locus were still in germ-line configuration, whereas 65 alleles underwent DH/H rearrangement (Fig.  3A) . D^j-to-Zn joining is usually imprecise at the recom bination breakpoint because of deletion of D^ and /^ sequences as well as insertion of template-independent nucleotides (N and P) (Desiderio et al. 1984; Lafaille et al. 1989) . The D^^H joints in Pax5-deficient B lymphocytes were normal in both of these aspects, as shown by DNA sequence analysis (Fig. 3B) . Importantly, neither V^Di^Ji^ nor VJ^ rearrangements could be detected in our sam ple of Pax5-deficient pre-BI cells (Fig. 3A) . This finding was not an artifact of the Vn'Specific primers used, as they were able to amplify efficiently Vj^D^J^-r&a.nanged alleles from individual pre-BII cells of wild-type mice TCCCG  CC  GTA TAT  TT  AGG  GAGGGGGGA  GCAT  T  GGG  TTT  GACG  C   JH  TAG TAT GCT ATG GAG TAG TGG  C TAT GGT ATG GAG TAG TGG  TAG TAT GGT ATG GAC TAC TGG  GCTTAG TGG  AC TAT GCT ATG GAC TAC TGG  TAC TAT GCT ATG GAC TAC TGG  TAC TGG  G TTT GCT TAC TGG  TAC TAT GCT ATG GAC TAC TGG  TT GCT TAC TGG  G CCT GGT TTG CTT TAC TGG  G CCT GGT TTG CTT TAC TGG  AC TAT GCT ATG GAC TAC TGG  C TAT GCT ATG GAC TAC TGG  C TGG TTT GCT TAC TGG  TAC TAT GCT ATG GAC TAC TGG  TAC TAT GCT ATG GAC TAC TGG  TAC TAT GCT ATG GAC TAC TGG  TG GAC TAC TGG  CC TGG TTT GCT TAC TGG  TAC TAT GCT ATG GAC TAC TGG  C TTT GAC TAC TGG  C TTT GAC TAC TGG  TAC TGG TAC TTC GAT GTC TGG  GCTATGGACTACTGG  GCT ATG GAC TAC TGG  GGGACGGTATGT  T PaxS (-/-) mice were stained and sorted as described in Fig. 2B . In total, 88 individual cells were subjected to PCR analysis ac cording to Ehlich et al. (1994) with the modifications described by ten Boekel et al. (1995) . Both IgH alleles were detected in 20 cases (23%), a single PCR band was ob served in 34 samples (38.5%) and no am plification was obtained in 34 cases (38.5%). Numbers refer to the occurrence of the different immunoglobulin gene rear rangements. (S) Junctional sequences of the Dn/H^rearranged IgH genes in PaxS-de ficient BllO^c-kit^ cells. DNA fragments amplified from 27 Dn/H-rearranged alleles were cloned and sequenced. The type of /H and DH segments used as well as the DH reading frame (RF; conventionally stan dardized relative to /H) were determined as described (Ichihara et al. 1989; Chang et al. 1992) . Template-independent nucleotides (N), which are inserted by terminal deoxynucleotidyl transferase (Alt and Baltimore 1982; Desiderio et al. 1984) , and short pal indromic sequences (P), which are comple mentary to the ends of the recombining gene segments (Lafaille et al. 1989) , are listed. N sequence insertion generated a stop codon in reading frame II of one DH/H" rearranged allele (indicated by asterisk), therefore preventing translation of the Dp protein.
(data not shown). The failure to detect V^H^H/H rear rangements in Pax5-deficient pre-BI cells is therefore sig nificant and contrasts with results obtained in previous single-cell PCR analyses of wild-type bone marrow cells. Ehlich et al. (1994) found that the early pro-B cells in Hardy's fraction B contain 24% (9/38) of all analyzed IgH alleles in the V^DH/pj-rearranged configuration. Like wise, ten Boekel et al. (1995) observed VHDH/H joining in 13% (4/30) of the IgH alleles analyzed from B220"c-]cit* pre-BI cells. Based on these two studies, we would have expected to identify 10-18 VH^H/H rearrangements among the 74 IgH alleles analyzed from Pax5-deficient pre-BI cells. The absence of any V^Di^Jj^-reannnged al lele strongly suggests that the incidence of Vi^-to-D^f^ rearrangement is at least 10-fold reduced in the absence of Pax5.
To verify the significance of this PCR result, we have sorted B220^c-kit^ cells from the bone marrow of wildtype and Pax5 mutant mice and used a pool of 10,000 cells rather than individual B lymphocytes as starting material for PCR amplification by the two-step protocol described above. As expected, IgH gene sequences could be amplified readily in germ-line and Dj^/^-rearranged configurations from both wild-type and three Pax5 mu tant mice (Fig. 4A ). In contrast, the pre-BI cells of only one of the three mutant mice gave rise to an amplifica tion product with VHJ558-specific primers. Therefore, VH-DH/H rearrangements involving members of the prominent VH/558 gene family were present in Pax5 mu tant mice just at the detection limit oi our PCR assay (Fig. 4A) . Similar results were also obtained by PCR am plification with primers specific for the 1^^7183 and VyfQ51 gene families (data not shown). As 70-80% of all VH^H/H rearrangements normally occur within these three V^^ gene families (Yancopoulos et al. 1988; Malynn et al. 1990 ), we conclude that VH^H/H rearrangements are rare in pre-BI cells of Pax5 mutant mice. The frequency of VH^H/H rearrangements in Pax5-de ficient B lymphocytes was next estimated by a quantita tive PCR assay. For this experiment we have sorted CD43^B220^ cells, as this population contains both ckit* and c-kit~ cells and therefore includes all B lympho cytes of Pax5-deficient bone marrow ( Fig. 2A) . Increasing numbers of B220*CD43* cells from Pax5 mutant and wild-type mice were analyzed by 30 cycles of PCR am plification with VH/558-specific primers. As shown in Figure 4B , only few VH^H/H rearrangements could be amplified from 10,000 B220^CD43" cells of Pax5 mutant mice in marked contrast with the situation observed with wild-type littermates. The amplified V^DH/H frag ments were quantitated by normalization to a PCR prod uct from the C]x region of the IgH locus that was used as a control for the number of genomes analyzed. As indi cated by this quantitation, the incidence of VH^H/H re arrangements in B220'^CD43" cells was 50-to 70-fold reduced in Pax5 mutant mice compared with wild-type animals. The combined results of all PCR experiments demonstrate therefore that the absence of Pax5 results in a low frequency of V^-to-D^^ rearrangements at the pre-BI cell stage. [A] PCR analysis of pre-BI cells. B220*c-kit* cells were sorted from the bone marrow of three Pax5 mutant mice (-/-) and one wild-type littermate (+/+) at the age of 2 weeks. Ten thousand of these pre-BI cells were subjected to the same two-step PCR amplification protocol that was used for the analysis of IgH gene rearrangements in single cells ( Fig. 3 ; Materials and Methods). PCR amplification products were detected by Southern blot hybridization with a 120-bp probe containing DNA sequences 3' of the /H4 segment. VH^H/H rearrangements involving members of the prominent VH/558 gene family were amplified with a VH/558-specific primer pair (Ehlich et al. 1994 ). Numbers at right refer to the /H segments used for rearrangement; the arrow points to the posi tion of the amplified germ-line fragment. Cloning and sequenc ing of the only VH^H/H fragment amplified from Pax5 (-/-) pre-BI cells indicated that it consisted of just one unique se quence, therefore corresponding to a single V^-to-D^Jff rear rangement event. {B] Quantitation of VH^^H/H rearrangements in B220*CD43* cells. Increasing numbers (300 to 10,000) of B220*CD43"' cells, which were sorted from the bone marrow of two mutant mice (-/-) and one wild-type littermate (+/+), were analyzed by 30 cycles of PCR amplification with a yH/558-specific primer pair, and the four different VH-DH/H fragments were detected by Southern blot analysis (see Materials and Methods). The autoradiographs shown were exposed for the same time period. A DNA segment from the C^i region of the IgH locus was amplified in parallel to control for the number of genomes analyzed. Quantitation of the VH-DH/H signals by Phosphorlmager analysis and normalization to the CJJ signal indicated a 50-to 70-fold lower incidence of VH-DH/H rearrangements in the PaxS mutant cells compared with the wild-type cells.
Long-term proliferation potential of PaxS-deficient pre-BI cells in vitro
The growth factor requirement of B-lymphoid cells pro vides yet a third criterion to define their developmental Stage. For instance, pre-BI cells from the bone marrow of wild-type mice can be cultured in vitro on stromal cells in the presence of IL-7 (Rolink et al. 1991b ). The long-term proliferation capacity of these cells is known to be criti cally dependent on the expression of c-kit and IL-7R (Rolink et al. 1991a; Sudo et al. 1993) , both of which are expressed on Pax5-deficient B lymphocytes ( Fig. 2A) . To examine the in vitro proliferation potential of these cells, we have used fluorescence-activated cell sorting to seed individual B220'^c-Ait"' cells from the bone marrow of Pax5 mutant mice into single wells containing stro mal ST2 cells and IL-7 medium. Under these conditions, one out of five cells grew into a colony that could be further propagated as a cell line in culture (data not shown). The same cloning frequency (1/5) was deter mined previously for B220"'c-foT cells isolated from the bone marrow of wild-type mice . Therefore, the absence of Pax5 does not affect the clonability of bone marrow pre-BI cells.
The cell surface phenotype of in vitro propagated pre-BI cells lacking Pax5 was next compared, by flow cyto metric analysis, with that of wild-type pre-BI cells. As shown in Figure 5 , both cell populations expressed simi lar levels of B220, c-kit, CD43, IL-7R, and VpreB, but differed in the synthesis of the BP-1 and CD 19 proteins, which were absent from Pax5-deficient pre-BI cells. These results combined with the in vivo data of Figure  2A indicate that, at this level of analysis, the Pax5-defi cient pre-BI cells have apparently not altered their phe notype on in vitro culturing.
B-cell-specific gene expression in Pax5-deficient pre-BI cells
BSAP (Pax5) is only one of several transcription factors that have essential roles in early B-cell development (for review, see Busslinger and Urbanek 1995) . The availabil ity of homogeneous pre-BI cell populations differing only by the presence or absence of Pax5 made it possible to investigate whether BSAP regulates the expression of other known transcription factors. As shown by the RNase protection experiment in Figure 6 , the expression of the transcription factors PU.l (Scott et al. 1994) , Ikaros (Georgopoulos et al. 1994) , EBF (Lin and Grosschedl 1995) , E2A (Bain et al. 1994; Zhuang et al. 1994) , Sox-4 (Schilham et al. 1996) , Oct-1 (Sturm et al. 1988 ), Oct-2 (Corcoran et al. 1993) , and OBF-1 (Kim et al. 1996; Schubart et al. 1996 ) was unaffected at the mRNA level by the absence of Pax5. Similarly, the Pax5 mutation did nei ther influence transcription of the recombination acti vating genes RAG-1 (Schatz et al. 1989) and RAG-2 (Oettinger et al. 1990 ) nor expression of the germ-line tran script Ip which initiates within the IgH enhancer region (Lennon and Perry 1985) . These latter observations are in agreement with our finding that Pax5-deficient pre-BI
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c-kit and Pax5 mutant (-/-) mice at the age of 2 weeks were plated under limiting dilution conditions on ST2 cells in the presence of IL-7. For each genotype, several pre-BI cell colonies were pooled 10 days later. After 24 days in culture, the growing pre-BI cell popu lations were subjected to flow cytometric analysis by staining with the indicated antibodies as described in the legend to Fig. 2A .
pre-B cells pre-B cells pre-B cells (Fig. 3) . The B-cell-specific genes coding for CD19 , Blk (Zwollo and Desiderio 1994) , XBP-1 (Reimold et al. 1996) , h5, and VpreBl (Okabe et al. 1992 ) have been suggested to be direct targets for regulation by the transcription factor BSAP (Pax5). However, of all these genes, only transcription of CD19 was reduced in the absence of Pax5 (Fig. 6) . Interestingly, not even basallevel expression of the CD19 gene could be detected in Pax5-deficient pre-BI cells in agreement with the observation that the CD19 protein was absent from the surface of these cells (Fig. 5) . These data therefore provide genetic evidence that CD19 expression is critically dependent on BSAP in contrast with the other genes tested.
Absence of B lymphopoiesis in the fetal liver of Pax5 mutant embryos During embryogenesis, B-cell development occurs predominantly in the fetal liver, which is highly enriched in B220'c-kit' B lymphocytes. These cells can be cloned from wild-type embryos at a high frequency in the presence of stromal cells and IL-7 . Consistent with this notion, we could readily establish pre-B-cell lines from fetal liver of wild-type (+/+) and heterozygous mutant (+/-) embryos at day 17 (Fig. 7A ). Much to our surprise however, we failed to clone any pre-B cells from the fetal liver of nine embryos lacking Pax5 Vpre blk (-1-1 (Fig. 7A) . This finding suggested strongly that the fetal liver is unable to support the development of early B-lymphoid progenitors in the absence of Pax5. This conclusion was confirmed by flow cytometric analysis of liver cells from day-17 fetuses ( Fig. 7BJ . B lymphocytes identified by the expression of the B-cell markers B220 and CD19 constitute only a small subset (3-4%) of all cells at this developmental age both in wild-type and heterozygous mutant embryos. Most of these B lymphocytes correspond, however, to progenitor cells as defined by the expression of c-kit on their cell surface. This progenitor cell population was entirely absent in the fetal liver of Pax5 mutant embryos (Fig. 7B) . To corroborate this result at the molecular level, we have analyzed, by RNase protection assay, the expression of the B-cell-specific genes B29, h5, VpreBI, and EBF in fetal liver of wild-type and mutant embryos (Fig. 8AJ . All of these genes are transcribed in a Pax5-independent manner at early stages of B-cell development as shown by their expression in Pax5-deficient pre-BI cells of bone marrow ( Fig. 6; unpubl. data). However, these genes were expressed in the fetal liver of homozygous mutant embryos (Urbanek et al. 1994 ) was detected by RNase protection assay in total RNA isolated from in vitro cultured bone marrow pre-B cells, from bone marrow of 16/19-day-old mice and from fetal liver of day-18.5 embryos of hetero zygous (+/-) and homozygous (-/-) mutant genotype. Tran scripts coding for the small ribosomal protein S16 were comapped as internal reference RNA. only at a very low level, if at all, compared with wildtype and heterozygous embryos (Fig. 8A) . In contrast, the Ikaros gene was equally well transcribed in the fetal liver of all three genotypes consistent with its broader expres sion pattern within the hematopoietic system (Georgopoulos et al. 1994) . In summary, the combined results of three experimental approaches (in vitro cloning, flow cy tometry, and expression analysis) demonstrate that mu tation of the Pax5 gene arrests B lymphopoiesis in the fetal liver at an even earlier developmental stage than in bone marrow. The two distinct phenotypes could in principle result from a difference in the developmental onset of Pax5 expression during fetal and adult B lymphopoiesis. To address this question, we have taken advantage of the fact that the targeted Pax5 allele carries an Escherichia coh lacZ gene under the transcriptional control of the endogenous locus (Urbanek et al. 1994) . RNase protec tion analysis of lacZ mRNA was therefore used to moni tor Pax5 expression in bone marrow, fetal liver, and in vitro cultured pre-BI cells of heterozygous and homozy gous mutant mice. As shown in Figure 8B , the lacZ gene was transcribed in both pre-B-cell lines to a similar level. In agreement with this observation, lacZ transcripts were also detected in bone marrow, where the disparity in transcript levels reflects the difference in B-lymphocyte numbers between heterozygous and homozygous mutant mice (Urbanek et al. 1994) . We conclude there fore that the Pax5 gene is transcribed even before the developmental stage at which B-cell differentiation is aborted in the bone marrow of Pax5-deficient mice. In contrast, no Pax5 transcripts could be detected in the fetal liver of homozygous mutant embryos (Fig. 8B) , therefore indicating that Pax5 is essential for fetal Blymphopoiesis right from the onset of its expression.
B-cell-autonomous effect of the Pax5 mutation
Early lymphocyte development is dependent strictly on the interaction with appropriate stromal cells in the pri mary lymphoid organs (Rolink and Melchers 1991) . In terestingly, stromal cells of the thymus express Pax-1, another member of the Pax family, and mutation of this gene in undulated mice interferes with stromal cell dif ferentiation, therefore resulting in abnormal T-cell de velopment (Wallin et al. 1996) . In analogy to this situa tion, it is also conceivable that a primary site of Pax5 function could be the stromal cells in bone marrow and that the block of B-cell development is merely the sec ondary consequence of abnormal stromal cell differen tiation in Pax5 mutant mice. To distinguish between such an indirect mode of action and a cell-autonomous effect of the PaxS mutation, we have reconstituted lethally irradiated wild-type mice by transplantation of bone marrow cells from PaxS-deficient donor mice. Three months after cell transfer, the reconstituted bone marrow of these mice contained only B220*CD43^ B lymphocytes, as shown by flow cytometric analysis (Fig.  9A ). The majority of these cells also expressed c-kit and IL-7R on their surface, which further identifies them as pre-BI cells. The absence of CD 19 expression on these B lymphocytes demonstrated efficient reconstitution of the bone marrow by Pax5 mutant donor cells. As illus trated by the absence of the late differentiation marker IgM and CD40, B-cell development was, however, still blocked completely in all B-lymphoid progenies of the transferred PaxS-deficient stem cell that was now em bedded in wild-type tissue. We conclude, therefore, that the effect of the PaxS mutation is B-cell autonomous.
To further investigate the nature of the early block in fetal B lymphopoiesis, we have also used fetal liver cells of PaxS mutant embryos to reconstitute the hematopoi etic system of lethally irradiated wild-type mice (Fig. 9B) . Interestingly, the bone marrow of these reconstituted mice was able to generate pre-BI cells expressing CD43, c-kit, and IL-7R quite in contrast with the fetal liver of the donor embryos. The B-cell phenotype is therefore identical in reconstituted mice regardless of whether PaxS-deficient fetal liver or bone marrow cells were used for transplantation. These data indicate that different functions of PaxS are required to support early B-cell 
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bone marrow (BM) cells from 16-day-old homozygous PaxS mutant mice (see Materials and Methods). [B]
Reconstitution with Pax5-deficient fetal liver cells. Lethally irradiated wild-type mice were rescued by injection of fetal liver (FL) cells from day-13.5 embryos lacking Pax5. In both cases, the B-cell compartment in the bone marrow of reconstituted mice was analyzed 3 months after transplantation by flow cytometry as described in the legend to Fig. 2A and in Materials and Methods.
development in the distinctive microenvironments of fe tal liver and adult bone marrow.
Discussion
Differential dependency of fetal and adult pro-B-cell development on PaxS
The developmental control genes of the Pax family are associated with mouse mutants and human disease syn dromes and code for transcription factors with important functions in embryonic pattern formation (for review, see Stuart et al. 1994) . One member of this gene family, PaxS, has an essential role not only in the morphogen esis of the developing midbrain, but also in early B lym phopoiesis (Urbanek et al. 1994 ). Here we have demon strated that B-cell development is arrested at the early pro-B (pre-BI) cell stage in the bone marrow of PaxS-de ficient mice. The B lymphocytes of these mice were identified as pre-BI cells on the basis of their expression of c-kit, IL-7R, CD43, HSA, X5, and VpreB as well as by the absence of CD25, BP-1, and later differentiation markers on the cell surface (see Fig. 1 ). Moreover, these PaxS-deficient pre-BI cells could be cultured in vitro in the presence of stromal cells and IL-7 with the same efficiency as the corresponding cells from wild-type bone marrow. Pre-BI cells could, however, not be detected in the fetal liver of PaxS mutant embryos as shown by the lack of in vitro clonable B lymphocytes and by an almost complete absence of B-cell-specific gene expression. PaxS is therefore required at two different developmental stages in fetal and adult B lymphopoiesis (Fig. 10) . In adult bone marrow, PaxS is essential for progression of B-cell development beyond the early pre-BI cell stage, whereas in the fetal liver it is required already for differ entiation of the earliest B-lineage-committed precursor cells. Bone marrow transplantation experiments further more demonstrated that the developmental block in adult B-lymphopoiesis results from a direct, cell autono mous effect of the PaxS mutation on B-cell differentia tion instead of being the indirect consequence of an in terference with stromal cell differentiation. Interest ingly, PaxS-deficient fetal liver cells could give rise to the development of pre-BI cells in reconstituted bone marrow, contrary to the situation encountered in the embryo. This apparent discrepancy may indicate a criti cal function of PaxS for stromal cell development in the fetal liver, although there is to date no evidence for PaxS expression in these cells. Therefore, we consider it more likely that the earliest B-cell progenitors depend for de velopment or survival in the fetal liver microenvironment on their own expression of BSAP (PaxS) Rolink et al. (1994) [top line) and Hardy et al. (1991) [bottom line in italics).
adult bone marrow. Consistent with this notion, Pax5 expression is indispensable right from its onset in fetal B lymphopoiesis, whereas its expression in pre-BI cells of the bone marrow does not appear to fulfill a critical func tion during early pro-B cell development. Differences between fetal and adult B lymphopoiesis have been observed previously. The enzyme terminal deoxynucleotidyl transferase (TdT), which is responsible for N sequence insertions in the -D^/H and VH-D^/H joints of the IgH gene, is not expressed in lymphocytes of the fetal liver in contrast to bone marrow (Desiderio et al. 1984; Li et al. 1993) . Similarly, the B-lymphoid-specific myosin light chain gene PLRLC is transcribed only in pre-B cells of the bone marrow, but not in fetal liver cells (Oltz et al. 1992; Li et al. 1993) . The hematopoietic pro genitor cells of fetal liver and bone marrow also differ in their capacity to regenerate the two different B-cell sub sets consisting of the conventional CDS" B lymphocytes and the CD5-expressing B-1 cells (for review, see Hardy and Hayakawa 1994; Kantor and Herzenberg 1993) . Fetal liver cells can efficiently reconstitute both B-cell popu lations in transplantation experiments, whereas bone marrow cells of adult donor mice predominantly give rise to conventional B lymphocytes (Kantor et al. 1992; Hardy and Hayakawa 1994) . These phenotypic differ ences are most probably not related to any PaxS function as both B-cell populations are equally dependent on this transcription factor for their development (Urbanek et al. 1994 ). To our knowledge, however, PaxS provides the first example of a transcription factor with distinct roles in fetal and adult B lymphopoiesis.
The PaxS gene is expressed in the B-lymphoid lineage up to the mature B-cell stage and consequently has also been implicated in the regulation of different aspects of late B-cell differentiation (for review, see Busslinger and Urbanek 199S) . For instance, PaxS is considered to be involved in the proliferation control of mature B lym phocytes, as antisense oligonucleotide inhibition of BSAP synthesis prevented splenic B-cells from entering the cell cycle on mitogenic stimulation . This hypothesis has recently gained support by the discovery that PaxS is recruited as an oncogene by t(9:14)(pl3;q32) translocations in a subset of nonHodgkin's lymphomas . This type of chromosomal translocation inserts the Ep enhancer of the IgH locus upstream of two PaxS promoters, which may interfere with the down-regulation of PaxS ex pression during plasma cell differentiation . In this regard it is, however, important to note that the early pre-BI cells of both wild-type and PaxSdeficient mice proliferate equally well in vivo and in vitro. Therefore, the proliferation of B lymphocytes does not require PaxS expression early in the lineage, but may become dependent on this transcription factor at later stages of B-cell differentiation.
Targeted gene inactivation in the mouse germ line was also used to elucidate the function of other transcription factors in the genetic control of B-cell differentiation. PU.l, a member of the Ets transcription factor family, appears to act high up in the transcriptional hierarchy, as disruption of its gene prevents the generation of progeni tors for both the lymphoid and myeloid lineages (Scott et al. 1994 ). Deletion of a subset of the zinc finger proteins encoded by the Ikaros locus results in complete failure of B-and T-cell development (Georgopoulos et al. 1994) . Once committed to the B-lymphoid lineage, cells be come dependent on the function of the EBF and E2A genes in addition to PaxS. Mice lacking the early B-cell factor EBF (Lin and Grosschedl 1995) or the helix-loophelix transcription factors E12 and E47 encoded by the E2A gene (Bain et al. 1994; Zhuang et al. 1994 ) are able to generate only a small number of CD43^B220^ cells in the bone marrow. In both cases, these early pro-B cells ex press a very limited set of B-cell-specific genes, contain the IgH locus still in germ-line configuration and do not transcribe the PaxS gene (Bain et al. 1994; Lin and Gros schedl 199S) . B-cell development appears therefore to be blocked at an earlier stage in the bone marrow of EBF and E2A mutant mice compared with animals lacking PaxS. However, a different situation prevails in fetal liver where PaxS is already required for full commitment to the B-lymphoid lineage. Progression of B-cell develop ment to the small pre-B-cell stage is furthermore depen dent on the function of the transcription factor Sox-4 (Schilham et al. 1996) , whereas Oct-2, OBF-1, and the pSO subunit of NF-KB have critical roles in the activation of mature B-cells to undergo plasma cell differentiation (Corcoran et al. 1993; Sha et al. 199S; Kim et al. 1996; Schubart et al. 1996) . Importantly, the expression of none of these regulatory genes was affected in PaxS-de ficient pre-BI cells. Therefore, PaxS does not appear to exert its effect on B-cell development by controlling the expression of other known transcription factors.
PaxS and the B-cell-specific control of V(D)J recombination
The somatic assembly of immunoglobulin heavy-and Cold Spring Harbor Laboratory Press on October 25, 2017 -Published by genesdev.cshlp.org Downloaded from light-chain genes from different coding segments is achieved in a highly regulated and temporally ordered fashion by the site-specific V(D)J recombination system (for review, see Lewis 1994) . Joining of the D^ and /H segments is initiated at the IgH locus soon after B-cell lineage commitment, and this process is completed on both IgH alleles at the early pro-B (pre-BI) cell stage (Ehlich et al. 1993; Li et al. 1993) . At this time in B-cell development, V^-to-Dj^Jf^ recombination is activated and then continues to operate until the late pro-B-cell stage (large pre-BII) (Ehhch et al. 1993; Li et al. 1993) when surface expression of a functionally rearranged ]i heavy-chain protein signals allelic exclusion and there fore prevents further rearrangement at the IgH locus . Using different PCR as says, we have demonstrated that the majority of the pre-BI cells in Pax5-deficient mice contain the IgH locus in the Dn/H-rearranged configuration. The frequency of VH-DH/H rearrangements is, however, reduced 50-fold in Pax5-deficient pre-BI cells compared with wild-type cells. These results therefore suggest an involvement of Pax5 in the pathway controlling V^-to-Df^l^ recombina tion.
The chromatin accessibility of the recombination sub strates appears to be a key factor in the control of the V(D)J rearrangement process as indicated by the obser vation that the transcription of germ-line immunoglob ulin gene segments usually precedes their DNA rear rangement (Yancopoulos and Alt 1985; Schlissel and Bal timore 1989; Schlissel et al. 1991b) . Transcriptional activation may therefore target immunoglobulin genes for V(D)J recombination. In agreement with this hypoth esis, V(D)J recombination is impaired by germ-line dele tion of the intronic enhancers of the IgH locus (Chen et al. 1993; Serwe and SabUtzky 1993) and IgU gene (Takeda et al. 1993) or by the lack of the Ep enhancer on transgenic recombination substrates (Ferrier et al. 1990 ). As both intronic enhancers do not contain any high-af finity binding sites for BSAP (Barberis et al. 1990) , it is unlikely that Pax5 mediates its effect on V(D)J recombi nation by direct interaction with these regulatory re gions. Alternatively, Pax5 may control V^-to-Di^J^^ rear rangements by activating germ-line V^ gene transcrip tion. The promoter activity of V^ ^^id V^ genes is known to critically depend on a regulatory sequence that is bound by the transcription factors Oct-1 and Oct-2 (Falkner and Zachau 1984; Mason et al. 1985) . However, both of these transcriptional regulators as well as their B-cell-specific coactivator OBF-1 (Kim et al. 1996; Schubart et al. 1996) are equally well expressed in the pres ence or absence of Pax5. To date we therefore do not have any evidence for either a direct or indirect role of Pax5 in transcriptional regulation underlying the VH^H/H rearrangement process.
It has been known for some time that -DH/H rearrange ments at the IgH locus promiscuously occur also in cells of the T-lymphoid lineage (Born et al. 1988; Cory et al. 1980; Kurosawa et al. 1981) . In contrast, Vj^-to-D^Jj^ re arrangements of the IgH gene take place only in B lym phocytes and therefore constitute a more stringently regulated step of the V(D)J recombination process. The ubiquitously expressed transcription factors of the E2A gene have been implicated in the control of DH/H rear rangements both by gain-and loss-of-function experi ments. Ectopic expression of the E47 protein resulted in the activation of DH/H, but not of VH^H/H rearrange ments in a pre-T-cell line (Schlissel et al. 1991a ). More over, the pro-B-cells of E2A-deficient mice neither ex press the recombination activating gene RAG-1 nor do they undergo D^-to-ZH rearrangements at the IgH locus (Bain et al. 1994) . Here we have shown that loss of the B-cell-specific transcription factor BSAP (Pax5) affects the B-lymphoid-restricted Vj^-to-D^^J^ joining step of IgH assembly. In this context it is of interest to note that the B-cell phenotype of Pax5-deficient mice differs at least in two aspects from that of mice with targeted dis ruption of genes involved in the expression of the pre-Bcell receptor. First, based on the expression of cell sur face markers, B-cell development appears to be arrested at an earlier stage in Pax5 mutant mice (early pro-B cells; fraction B) than in mice lacking RAG-1, Ig^, \5 (X5T), the joining region (/^T) or the membrane exon (pMT) of the IgH locus, all of which are blocked at the late pro-B-cell stage (fraction C) (Ehlich et al. 1993; Spanopoulou et al. 1994; Gong and Nussenzweig 1996) . Second, expression of a rearranged p heavy-chain transgene in Pax5 mutant mice did not allow B lymphocytes to advance in B-cell development (C. Thevenin and M. Busslinger, unpubl.) in contrast with the situation observed with RAG-deficient mice where complementation with a p transgene facilitates progression to the small pre-B cell stage Spanopoulou et al. 1994; Young et al. 1994) . The lack of complementation therefore indicates that the failure to undergo Vy^-to-Dj^lyi rearrangements is unlikely to be the reason for the developmental block observed in the bone marrow of Pax5 mutant mice.
Regulation of B-cell-specific gene expression by BSAP (Pax5)
Insight into the regulatory function of BSAP critically depends on the identification of genes that are controlled by this transcription factor. The in vitro clonability of Pax5-deficient pre-BI cells now provides a useful tool to search for such target genes. Comparative expression analysis of over 30 known B-cell-specific genes in wildtype and Pax5-deficient pre-BI cells resulted in the iden tification of three genes, CD19, mb-l{Iga] and N-myc, which are down-regulated in the absence of BSAP at this early stage of B-cell development. Whereas the levels of N-myc and mb-1 transcripts were reduced consistently (S. Nutt, unpubl.), expression of the CD19 gene was en tirely lost in Pax5-deficient pre-BI cells (Fig. 6 ). In accord with this finding, we have identified previously a highaffinity BSAP-binding site in the -30 region of the CD 19 gene, which is fully occupied in vivo in B cells and is therefore likely to mediate BSAP-dependent transcrip tional initiation . Moreover, CD19 expression can be induced readily in an estrogen-depen dent manner in Pax5-deficient pre-BI cells expressing a BSAP-estrogen receptor fusion protein (S. Nutt, unpubl.) . Together, these data unequivocally identify CD 19 as a genuine BSAP target gene. The expression of blk, XBP-1, X5, and VpreBl was, however, unaffected by the absence of BSAP, which strongly argues against a critical role of this transcription factor in the regulation of these genes in apparent contradiction to published data (Okabe et al. 1992; Zwollo and Desiderio 1994; Reimold et al. 1996) .
Could the lack of CD 19 expression be responsible for the early arrest of B-cell development in Pax5-deficient mice? The CD 19 protein is known to associate with sur face immunoglobulin receptors where it acts as a costimulatory molecule to lower the threshold for antigendependent signaling (Carter and Fearon 1992) . In agree ment with this function, the processes of B-cell activation, selection and maturation are impaired se verely in mice lacking CD 19 (Engel et al. 1995; Rickert et al. 1995) . However, B-lymphoid development up to the mature B-cell stage was unperturbed in the bone marrow of these mice, demonstrating that CD : Z 9 cannot be one of the critical target genes responsible for the differentia tion block in PaxS mutant mice. Therefore, we will have to face the challenge to systematically search for such target genes, which should be facilitated greatly by the availability of Pax5-deficient pre-BI cell lines.
Materials and methods
Mice
All analyses including the bone marrow transplantation experi ments were performed with wild-type and PaxS mutant mice that were bred on the hybrid background C57BL/6 x 129/Sv (Urbanek et al. 1994 ). The PaxS genotype was determined by Southern blot analysis (Urbanek et al. 1994) or by PCR assay using the following oligonucleotides: 5'-ACAGTCCCCTTAC-CCCTTCCCCCAAATGAA-3' (primer 1); 5'-GTCCCTCCT-AACAAAGTCTCCCTATTCCAC-3' (primer 2); and 5'-GT-GAGCGAGTAACAACCCGTCGGATTCTCC-3' (primer 3). A 693-bp PCR product was amplified from the wild-type PaxS allele with primer pair 1 jl and a 783-bp DNA fragment from the mutant lacZ allele with the pair 1/3.
Antibodies and flow cytometric analysis
The following monoclonal antibodies were purified from hybridoma cell supernatants on protein G-sepharose columns (Pharmacia, Uppsala, Sweden) and conjugated with Sulfo-NHSBiotin (Pierce Chemical Company) as recommended by the supphers: anti-CD19 mAb (1D3; Krop et al. 1996) , anti-c-Ait mAb (ACK4; Ogawa et al. 1991) , anti-IL-7R mAb (A7R34; Sudo et al. 1993) , anti-VpreB mAb (VP245; Karasuyama et al. 1993) , and anti-jLiH chain mAb (M41; Leptin et al. 1984) . Anti-B220/ CD45R mAb (RA3-6B2) was obtained as fluorescein isothiocyanate (FITC)-conjugated antibody from PharMingen (San Diego, CA), whereas all other monoclonal antibodies were purchased from the same company in biotinylated form: anti-CD25/TAC mAb (7D4), anti-CD43 (S7), anti-BP-1 (6C3), and anti-HSA/ CD24 (Ml/69). Phycoerythrin (PE)-conjugated streptavidin was obtained from Southern Biotechnology Associates Inc. (Bir mingham, Alabama).
Single-cell suspensions were prepared from bone marrow and fetal liver, stained with different antibody combinations and then analyzed by a FACScan flow cytometer (Becton-Dickinson) as described previously (Urbanek et al. 1994) .
Fluorescence-activated cell sorting and cell cycle analysis
Bone marrow cells of 2-week-old PaxS mutant mice were stained with anti-B220/CD45R (RA3-6B2) and anti-c-iat (ACK4) antibodies and then separated into B220^c-icit^ and B220'"c-Air cell fractions by fluorescence-activated cell sorting using a FACStar''^"'' flow cytometer. Reanalysis of the sorted cells indicated a purity of 5=90% for each cell population. Cell cycle analysis was performed by fixing the sorted cells followed by ethidium bromide staining of isolated nuclei and FACScan analysis of their DNA content as described previously ).
Transplantation of bone marrow and fetal liver cells
Wild-type female mice (C57BL/6 x 129/Sv) at the age of 2 months were lethally 7-irradiated with 950 rads (9.5 Gy) and then provided with 2 x 10^ to 7 x 10^ bone marrow cells from 16-day-old homozygous PaxS mutant mice (C57BL/6 x 129/Sv) by injection into the tail vein. In a second experimental series, wild-type recipient mice of the same age and strain background were lethally irradiated and subsequently received 3 x 10^ to 5 x 10^' fetal liver cells prepared from day-13.5 embryos (C57BL/ 6 x 129/Sv) lacking PaxS. The B-cell compartment of the recipi ent mice was analyzed by flow cytometry 3 months after cell transfer.
PCR analysis of IgH gene rearrangements
Single-cell PCR analyses (Fig. 3) were performed with individual B220"^c-kit'' cells that were sorted from bone marrow of twoweek-old PaxS mutant mice into single wells of a 96-well plate by a FACStar^^'^^ flow cytometer. The IgH and IgL^ gene loci of individual cells were amplified exactly according to the twostep PCR protocol of ten Boekel et al. (1995) , which is based on the method of Ehlich et al. (1994) . Only the first (Gu et al. 1991) of the two DHFL16/DHSP2-specific 5' primers listed in Table 1 of ten Boekel et al. (1995) was used for PCR amplification of Dj^J^-teairanged alleles which resulted in DNA fragments of the following sizes: 1880 bp (/"!), 1560 bp (/H2), 1180 bp (/H3), and 610 bp (/H4). The products of the second PCR reaction were cloned directly into the dT-tailed vector pCRII (Invitrogen) and then verified by DNA sequencing. The same two-step PCR protocol was also employed for the amplification of rearranged IgH alleles from 10,000 B220*c-kit'^ cells that were sorted from the bone marrow of either wild-type or PaxS-deficient mice. Only 25 cycles of amplification were used for each of the two PCR reactions, and the amplified DNA fragments were analyzed by Southern blot hybridization with a 120-bp /H4-specific DNA probe. In this assay, VH^H/H recom bination generated DNA fragments of the following sizes: 1720 bp (/H1), 1410 bp (/H2), 990 bp (/H3) and 460 bp (/H4). A 1500-bp PCR product was indicative of the IgH germ-line configuration.
For quantitation of VH£>H/H recombination, the rearranged alleles of the V^JSSS gene family were amplified by 30 PCR cycles with a yn/SSS-specific primer pair (Ehlich et al. 1994 ) from increasing numbers of B220"'CD43"' cells that were sorted from the bone marrow of mutant and wild-type mice. As control for the number of B220"CD43-' ceUs analyzed, a 2050-bp frag ment was amplified from the Cp region of the IgH locus with primers described previously ).
Establishment of pre-B-cell lines
Cell suspensions from bone marrow and fetal liver of wild-type and PaxS mutant mice were plated at limiting dilutions on a semi-confluent layer of stromal cells in the presence of IL-7 medium exactly as described (Relink et al. 1991b (Relink et al. , 1993 . ST2 cells (Ogawa et al. 1988 ) that were 7-irradiated with -1100 rads (11 Gy) in a Gammacell 40 machine were used as stromal cells. The IL-7-containing medium consisted of Iscove's modified Dulbecco's medium (IMDM) supplemented with 2% heat-inac tivated fetal calf serum, 0.03% (wt/vol) primatone RL (Quest International, Naarden, The Netherlands), 50 JJM 2-mercaptoethanol, 1 mM glutamine, and 1% conditioned supernatant of rIL-7-producing f558L cells . After 1 week of in vitro culture, several pre-B-cell colonies were pooled and fur ther propagated as a cell line.
Riboprobes and RNase protection assay
The following oligonucleotide pairs were used for PCR ampli fication of the indicated riboprobes: mPU.l, 5'-GCGGAATTCGCGACATGAAGGACAGCATCT-3' and 5'-GCGAAGCTTGCTGAACTGGTAGGTGAGCTT-3'; mlkaros, 5' -GCGGAATTCGCTGCCAAGACTCCACAGATA-3' and 5'-GCGAAGCTTTGCTCGCCACTCGTGCTGAC-3'; mEBF, 5' -GCGGAATTCACAATAACTCCAAGCACGGG-3' and 5' -GCGAAGCTTGGCATGAGGAGTTATCAACTC-3'; mE2A, 5' -GCGGAATTCCCCAACTACGATGCAGGTCT-3' and 5' -GCGAAGCTTGAGGTCTCTGTGAGAGGTCA-3'; mSox-4, 5'-GCGAAGCTTTTATGGTGTGGTCGCAGATCG-3' and 5'-GCGAAGCTTGTTGCCCGACTTCACCTTCTT-3'; mOct-1, 5'-GCGGAATTCTCCAGTGAAGAGTCGGGAGA-3' and 5'-GCGAAGCTTATCTGTATGGGCTGAGACAGG-3'; mOct-2, 5'-GCGGAATTCCTGCACATGGAGAAG-GAAGTG-3' and 5' -GCGAAGCTTCAGACTGCTAGAAGCT-TGGGA-3'; mOBF-I, 5'-GCGGAATTCACCTCCACCCT-GCAGTACCA-3' and 5'-GCGAAGCTTGCCTTCCA-CAGAGAGAGTGTGG-3'; and mVpreBl, 5'-GCG-GAATTCTCCCAGGTTCCTGCTGAGATA-3' and 5'-GCGAAGCTTCGACTTTTCTCCTTCCCACTC-3'; mX5: 5'-GCGGAATTCTCAGCAGAAAGGAGCAGAGCT-3' and 5'-GCGAAGCTTACACACTACGTGTGGCCTTGT-3'; mRAG-1, 5'-GCGGAATTCGGAACTCCTCTCCACCAGTT-3' and 5'-GCGAAGCTTCAGCCAGTGATGTTTCAGGAC-3'; mRAG-2, 5'-GCGGAATTCGGACTCCACTCCCTTT-GAAGA-3' and 5' -GCGAAGCTTATCCATCGACTGGGCAT-GTAC-3'; mlp, 5'-GCGGAATTCCCTGGGAATGTATGGTT-GTGG-3' and 5'-GCGAAGCTTATGGGCACATGCA-GATCTCTG-3'; mB29, 5'-GCGGAATTCCTGTGGCAC-GGAACTTCTAGT-3' and 5'-GCGAAGCTTCCTGTCC-GAAGAGTCACTATG-3'; mXBP-1, 5'-GCGGAATTCAC-CATGGTGCCTAGTGTTCC-3' and 5'-GCGAAGCTTTCT-GAGGAGTTGTGTGAGCT-3'. cDNA transcribed from poly(A)* RNA of the murine pre-Bcell line 70Z/3 was used as template for PCR amplification of PU.l, EBF, Oct-1, OBP-1, XBP-1, and I]i sequences with the primers indicated above. E2A, VpreBl, \5, , and B29 sequences were amplified from the respective cDNA clone Hermanson et al. 1988; Schatz et al. 1989; Oettinger et al. 1990; Walker et al. 1990; Wirth et al. 1991) . All amplified cDNA fragments were cloned in the antisense orientation into the Hindlll and £coRI sites of pSP64. The S16 and lacZ riboprobes have been described previously (Urbanek et al. 1994) . A 260-bp BamHl-EcoRl frag ment of plasmid pZipNeo-mCD19 ) and a 150-bp Apal-HinAlll fragment of the blk cDNA clone 102 (Dymecki et al. 1990) were inserted into the poly linker of pSP64 to obtain the CD19 and blk riboprobes, respectively. All subclones were verified by DNA sequencing.
Total RNA was prepared from mouse tissues and pre-B-cell lines using the Trizol reagent (GIBCO-BRL), and 10-20 pg of each RNA preparation were analyzed by RNase protection assay according to Vitelli et al. (1988) except that a hybridization tem perature of 60°C was used.
